New evidence summary on hydroxychloroquine and COVID-19

With evidence about medicines, tests and treatments for COVID-19 being updated at a blinding pace, NPS MedicineWise is regularly reviewing the latest evidence and publishing the findings in one convenient place.

Comprehensive information for health professionals on hydroxychloroquine is the latest addition to the NPS MedicineWise COVID-19 information hub.

The new article for health professionals includes:

• What is hydroxychloroquine?
• What are the interactions with other medicines?
• What are the known adverse effects of hydroxychloroquine?
• What is the evidence around COVID-19?
• What is the advice in different countries?

The article complements an earlier article written for consumers which reminded them that currently there is no evidence to support the use of hydroxychloroquine as a treatment for COVID-19 outside of the hospital setting.

An editorial published in Australian Prescriber last week also looked at principles of ethical prescribing for self and others: hydroxychloroquine in the COVID‑19 pandemic.

NPS MedicineWise is independent and evidence-based, and is a reliable source of continually updated and curated information about medicines, tests and treatments during the COVID-19 pandemic.